Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview (2023)
Source: Journal of Controlled Release. Unidade: FCF
Subjects: QUIMIOTERAPIA, RADIOTERAPIA, ANTINEOPLÁSICOS
ABNT
CASTRO, Karine Cappuccio de et al. Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview. Journal of Controlled Release, v. 353, p. 802-822, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2022.12.017. Acesso em: 23 ago. 2024.APA
Castro, K. C. de, Coco, J. C., Santos, É. M. dos, Ataide, J. A., Martinez, R. M., Nascimento, M. H. M. do, et al. (2023). Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview. Journal of Controlled Release, 353, 802-822. doi:10.1016/j.jconrel.2022.12.017NLM
Castro KC de, Coco JC, Santos ÉM dos, Ataide JA, Martinez RM, Nascimento MHM do, Prata J, Fonte PRML da, Severino P, Mazzola PG, Baby AR, Souto EB, Araujo DR de, Lopes AM. Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview [Internet]. Journal of Controlled Release. 2023 ; 353 802-822.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.jconrel.2022.12.017Vancouver
Castro KC de, Coco JC, Santos ÉM dos, Ataide JA, Martinez RM, Nascimento MHM do, Prata J, Fonte PRML da, Severino P, Mazzola PG, Baby AR, Souto EB, Araujo DR de, Lopes AM. Pluronic® triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview [Internet]. Journal of Controlled Release. 2023 ; 353 802-822.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.jconrel.2022.12.017